PT2576505T - Processo para a preparação de pleuromutilinas - Google Patents

Processo para a preparação de pleuromutilinas

Info

Publication number
PT2576505T
PT2576505T PT117249383T PT11724938T PT2576505T PT 2576505 T PT2576505 T PT 2576505T PT 117249383 T PT117249383 T PT 117249383T PT 11724938 T PT11724938 T PT 11724938T PT 2576505 T PT2576505 T PT 2576505T
Authority
PT
Portugal
Prior art keywords
pleuromutilin
crystalline form
crystalline
Prior art date
Application number
PT117249383T
Other languages
English (en)
Inventor
Riedl Rosemarie
Heilmayer Werner
Spence Lee
Original Assignee
Nabriva Therapeutics Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nabriva Therapeutics Ag filed Critical Nabriva Therapeutics Ag
Publication of PT2576505T publication Critical patent/PT2576505T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C07C319/20Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40Y being a hydrogen or a carbon atom
    • C07C323/41Y being a hydrogen or an acyclic carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/43Y being a hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/08Acetic acid
    • C07C53/10Salts thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13Dicarboxylic acids
    • C07C57/145Maleic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/08Lactic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/58Ring systems containing bridged rings containing three rings
    • C07C2603/76Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members
    • C07C2603/80Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing eight-membered rings
    • C07C2603/82Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing eight-membered rings having three condensed rings with in total fourteen carbon atoms and having a having a [5.4.3.0(1,8)] ring structure, e.g. pleuromutiline
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT117249383T 2010-05-26 2011-05-23 Processo para a preparação de pleuromutilinas PT2576505T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20100450092 EP2399904A1 (en) 2010-05-26 2010-05-26 Process for the preparation of pleuromutilins

Publications (1)

Publication Number Publication Date
PT2576505T true PT2576505T (pt) 2018-03-05

Family

ID=42937801

Family Applications (2)

Application Number Title Priority Date Filing Date
PT117249383T PT2576505T (pt) 2010-05-26 2011-05-23 Processo para a preparação de pleuromutilinas
PT171973506T PT3299356T (pt) 2010-05-26 2011-05-23 Processo para a preparação de pleuromutilinas

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT171973506T PT3299356T (pt) 2010-05-26 2011-05-23 Processo para a preparação de pleuromutilinas

Country Status (29)

Country Link
US (1) US9120727B2 (pt)
EP (3) EP2399904A1 (pt)
JP (2) JP6038021B2 (pt)
KR (1) KR101935333B1 (pt)
CN (2) CN105111117A (pt)
AU (1) AU2011257938B2 (pt)
BR (1) BR112012029982A2 (pt)
CA (1) CA2799029C (pt)
DK (2) DK3299356T3 (pt)
EA (1) EA023273B1 (pt)
ES (2) ES2909198T3 (pt)
HR (1) HRP20220201T1 (pt)
HU (2) HUE035861T2 (pt)
IL (1) IL222999A (pt)
MA (1) MA34332B1 (pt)
MX (1) MX347176B (pt)
MY (1) MY164666A (pt)
NZ (1) NZ603804A (pt)
PH (1) PH12012502321A1 (pt)
PL (2) PL3299356T3 (pt)
PT (2) PT2576505T (pt)
SG (1) SG185104A1 (pt)
SI (1) SI3299356T1 (pt)
TN (1) TN2012000506A1 (pt)
TR (1) TR201802636T4 (pt)
TW (1) TWI585073B (pt)
UA (1) UA108378C2 (pt)
WO (1) WO2011146954A1 (pt)
ZA (1) ZA201208056B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104447294A (zh) * 2014-11-24 2015-03-25 苏州乔纳森新材料科技有限公司 一种3-环己烯-1-甲酸的手性拆分方法
KR102656841B1 (ko) * 2015-06-17 2024-04-12 나브리바 테라퓨틱스 게엠베하 레파뮬린의 주사가능한 약제학적 제형
RS57328B1 (sr) 2015-06-18 2018-08-31 Mithra Pharmaceuticals S A Orodisperzibilna dozna jedinica koja sadrži estetrolsku komponentu
NZ737945A (en) 2015-06-18 2023-06-30 Estetra Sprl Orodispersible dosage unit containing an estetrol component
TWI762573B (zh) * 2017-02-10 2022-05-01 奧地利商納畢瓦治療有限責任公司 截短側耳素之純化
CN107417586A (zh) * 2017-06-21 2017-12-01 华南农业大学 一种截短侧耳素类抗生素及其制备方法和应用
CR20200486A (es) 2018-04-19 2021-01-27 Estetra Sprl Compuestos y sus usos para aliviar los síntomas asociados a la menopausa
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
TWI755055B (zh) * 2019-09-18 2022-02-11 台灣神隆股份有限公司 用於製備惡拉戈利鈉及其中間體的方法
CN111170893B (zh) * 2020-01-19 2022-04-26 郑州依米花手性药物研究有限公司 Lefamulin的中间体化合物及其在Lefamulin制备中的应用
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
JP2023522644A (ja) * 2020-04-17 2023-05-31 ナブリバ セラピューティクス ゲーエムベーハー プレウロムチリンの治療的使用
EP4135681B1 (en) 2020-04-17 2025-06-25 Nabriva Therapeutics GMBH Antiviral use of pleuromutilins
EP4475834A1 (en) 2022-02-09 2024-12-18 Nabriva Therapeutics GMBH Lefamulin and its derivatives for use in the treatment of a spiral shaped bacteria
EP4338732A1 (en) 2022-09-16 2024-03-20 Nabriva Therapeutics GMBH Lefamulin and its derivatives for use in the treatment of tularemia
CN118894800A (zh) * 2024-06-27 2024-11-05 福建省微生物研究所 一种Lefamulin中间体化合物的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61207370A (ja) * 1985-03-11 1986-09-13 Seitetsu Kagaku Co Ltd 4−(メタンスルホニルオキシ)チオフエノ−ルの製法
GB0017031D0 (en) * 2000-07-11 2000-08-30 Biochemie Gmbh Antimicrobials
ES2295657T3 (es) * 2002-07-24 2008-04-16 Nabriva Therapeutics Forschungs Gmbh Derivados de pleuromutilina como antimicrobianos.
GB0308114D0 (en) * 2003-04-08 2003-05-14 Glaxo Group Ltd Novel compounds
MXPA06000955A (es) * 2003-08-04 2006-03-30 Grindeks Jsc Sales de meldonio, metodo para su preparacion y composiciones farmaceuticas basadas en ellas.
PL1658277T3 (pl) * 2003-08-18 2012-10-31 H Lundbeck As Sól bursztynianowa i malonianowa trans-4-((1R,3S)-6-chloro-3-fenyloindan-1-ylo)-1,2,2-tri-metylopiperazyny i zastosowanie jako lek
EP2181995A3 (en) * 2003-09-03 2010-06-16 Glaxo Group Limited Salts and crystalline form of mutilin 14-(exo-8-methyl-8-azabicyclo[3.2.1]oct-3-yl-sufanyl)-acetate
US9697672B2 (en) 2006-07-20 2017-07-04 Bally Gaming, Inc. Wagering game with special-event eligibility feature based on passive game play
EP1908750A1 (en) * 2006-10-05 2008-04-09 Nabriva Therapeutics Forschungs GmbH Process for the preparation of pleuromutilins
ATE449062T1 (de) * 2007-02-22 2009-12-15 Indena Spa Verfahren zur herstellung von (2r,3s)-3- phenylisoserin-methylester-acetatsalz
EP1972618A1 (en) 2007-03-20 2008-09-24 Nabriva Therapeutics AG Pleuromutilin derivatives for the treatment of diseases mediated by microbes
EP2014645A1 (en) * 2007-07-13 2009-01-14 Nabriva Therapeutics AG Pleuromutilin derivatives and their use as antimicrobials
EP2159220A1 (en) * 2008-09-02 2010-03-03 Nabriva Therapeutics AG Organic compounds

Also Published As

Publication number Publication date
EA023273B1 (ru) 2016-05-31
CA2799029A1 (en) 2011-12-01
CN105111117A (zh) 2015-12-02
TN2012000506A1 (en) 2014-04-01
WO2011146954A1 (en) 2011-12-01
ZA201208056B (en) 2014-01-29
EP2576505B1 (en) 2017-11-29
IL222999A0 (en) 2013-02-03
IL222999A (en) 2016-02-29
MA34332B1 (fr) 2013-06-01
PT3299356T (pt) 2022-02-21
HUE035861T2 (hu) 2018-06-28
AU2011257938B2 (en) 2016-06-23
PL2576505T3 (pl) 2018-05-30
HRP20220201T1 (hr) 2022-04-29
BR112012029982A2 (pt) 2020-09-01
TWI585073B (zh) 2017-06-01
DK3299356T3 (da) 2022-01-31
EP3299356A1 (en) 2018-03-28
UA108378C2 (uk) 2015-04-27
KR101935333B1 (ko) 2019-01-04
MX347176B (es) 2017-04-17
EP2399904A1 (en) 2011-12-28
KR20130079406A (ko) 2013-07-10
ES2659729T3 (es) 2018-03-19
EP3299356B1 (en) 2021-11-24
HK1253006A1 (en) 2019-06-06
DK2576505T3 (en) 2018-03-05
HUE057587T2 (hu) 2022-05-28
CN103080083A (zh) 2013-05-01
CN103080083B (zh) 2016-03-02
US9120727B2 (en) 2015-09-01
TR201802636T4 (tr) 2018-03-21
MX2012013645A (es) 2013-05-01
MY164666A (en) 2018-01-30
US20130079400A1 (en) 2013-03-28
NZ603804A (en) 2014-03-28
SG185104A1 (en) 2012-12-28
PH12012502321A1 (en) 2013-02-11
TW201209026A (en) 2012-03-01
PL3299356T3 (pl) 2022-04-04
JP6038021B2 (ja) 2016-12-07
ES2909198T3 (es) 2022-05-05
SI3299356T1 (sl) 2022-05-31
EP2576505A1 (en) 2013-04-10
JP2016210804A (ja) 2016-12-15
EA201291370A1 (ru) 2013-09-30
JP6501742B2 (ja) 2019-04-17
JP2013528162A (ja) 2013-07-08
CA2799029C (en) 2019-01-29

Similar Documents

Publication Publication Date Title
PL2576505T3 (pl) Postać krystaliczna pleuromutyliny
SG10201500451TA (en) Crystalline forms of a purine derivative
ZA201600680B (en) A method of motion compensation
PT2723544T (pt) Construção de uma torre
ZA201301802B (en) Besylate salt of a btk inhibitor
IL256533B (en) A method for the production of inganol-3-englate
PL2589796T3 (pl) Wytwarzanie sekcji nasadowej
PT2611779T (pt) Formas cristalinas de um inibidor do fator xa
ZA201308393B (en) Production of acetyl-coenzyme a derived compounds
SG10201501226VA (en) New crystalline form of a cyclopropyl benzamide derivative
GB201004096D0 (en) Production of polyhydroalkanoates
IL230183A0 (en) Synthesis of callistantin a and its derivatives
IL223584A0 (en) Crystalline form of a 3-phenoxymethylpyrrolidine compounds
ZA201406238B (en) Crystalline form of a succinate salt
PL2407612T3 (pl) Zastosowanie skrzynki zbrojenia
IL230977A (en) A crystalline form of relapaldib
TWM390210U (en) Improved structure of a tool holder
GB2497112B (en) Manufacture of a package
TWM390844U (en) Structure improvement of a screwdriver
TWM402373U (en) Improved structure of a faucet
TWM402641U (en) Structure of a place box
TWM385440U (en) Structure improvement of a screwdriver
HK1178531A (zh) 环丙基苯甲酰胺衍生物的新结晶形式
IL231452A0 (en) Amorphous form of dolutegravir
GB201115520D0 (en) New design of a toothbrush